COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study

BACKGROUND: Coronavirus disease 2019 (COVID-19) vaccine has played a major role in ending the pandemic. However, little is known about the influence of COVID-19 vaccine on the efficacy of immunotherapy in patients with non-small cell lung cancer (NSCLC). OBJECTIVES: The goal of this study is to expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yunfei, Zhu, Zhuxian, Mo, Yin-Yuan, Zhang, Ziqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485982/
https://www.ncbi.nlm.nih.gov/pubmed/37679851
http://dx.doi.org/10.1186/s13027-023-00526-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485982/
https://www.ncbi.nlm.nih.gov/pubmed/37679851
http://dx.doi.org/10.1186/s13027-023-00526-7

Ejemplares similares